Andreas Hansch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Hansch has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Oliver Frey
Institute of Pathology, Friedrich Schiller University of Jena, Ziegelmühlenweg 1, D‐07740 Jena, Germany
2 shared publicationsRolf Bräuer
Institute of Pathology, Friedrich Schiller University of Jena, Ziegelmühlenweg 1, D‐07740 Jena, Germany
2 shared publicationsWerner A. Kaiser
Institute of Diagnostic and Interventional Radiology, Friedrich Schiller University of Jena, Bachstrasse 18, D‐07743 Jena, Germany
2 shared publicationsAnsgar Malich
Friedrich Schiller University Jena, Jena, Germany
1 shared publicationDieter Sauner
Friedrich Schiller University Jena, Jena, Germany
1 shared publicationGraefe Susanna
Biolitec, Winzerlaer Straße 2, 07745 Jena, Germany
1 shared publication
Latest Publications
- 15 April 2008
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 40 (4) , 265-272
Photodynamic treatment as a novel approach in the therapy of arthritic joints
Background and Objective Minimal invasive local treatment of joints is a desirable option in the therapy of rheumatoid arthritis (RA). Aim of this study was to evaluate the effects of photodynamic treatment (PDT) with different doses of the photosensitizer meta‐tetra(hydroxyphenyl)chlorin (m‐THPC; or temoporfin) in a murine model of RA (antigen‐induced arthritis, AIA). Methods In vivo distribution The distribution of native and liposomal m‐THPC (including a formulation with polyethylene glycol [PEG] coating) was assessed by fluorescence spectrometry in arthritic joints, normal joints, and skin. Treatment AIA mice received different concentrations of pegylated liposomal m‐THPC (0.1, 0.05, 0.01, or 0.005 mg/kg body weight; n = 5 per group) and subjected to PDT with a laser system 12 hours post‐injection of the photosensitizer. Treatment effects were evaluated histologically in comparison to untreated AIA (n = 5). Results Pegylated liposomal m‐THPC showed the most favorable accumulation in arthritic joints compared to native m‐THPC and to non‐peg‐liposomal m‐THPC, therefore it was selected as photosensitizer for PDT treatment. In comparison to untreated AIA, PDT reduced the arthritic score with all doses of pegylated liposomal m‐THPC; statistical significant effects were obtained with doses of 0.05 and 0.01 mg/kg. Conclusion Our study demonstrated that local PDT of arthritic joints is feasible. Application of pegylated liposomal m‐THPC for PDT resulted in significant reduction of arthritis scores. Lasers Surg. Med. 40:265–272, 2008.
- 15 April 2008
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 40 (4) , 265-272
Photodynamic treatment as a novel approach in the therapy of arthritic joints
Background and Objective Minimal invasive local treatment of joints is a desirable option in the therapy of rheumatoid arthritis (RA). Aim of this study was to evaluate the effects of photodynamic treatment (PDT) with different doses of the photosensitizer meta‐tetra(hydroxyphenyl)chlorin (m‐THPC; or temoporfin) in a murine model of RA (antigen‐induced arthritis, AIA). Methods In vivo distribution The distribution of native and liposomal m‐THPC (including a formulation with polyethylene glycol [PEG] coating) was assessed by fluorescence spectrometry in arthritic joints, normal joints, and skin. Treatment AIA mice received different concentrations of pegylated liposomal m‐THPC (0.1, 0.05, 0.01, or 0.005 mg/kg body weight; n = 5 per group) and subjected to PDT with a laser system 12 hours post‐injection of the photosensitizer. Treatment effects were evaluated histologically in comparison to untreated AIA (n = 5). Results Pegylated liposomal m‐THPC showed the most favorable accumulation in arthritic joints compared to native m‐THPC and to non‐peg‐liposomal m‐THPC, therefore it was selected as photosensitizer for PDT treatment. In comparison to untreated AIA, PDT reduced the arthritic score with all doses of pegylated liposomal m‐THPC; statistical significant effects were obtained with doses of 0.05 and 0.01 mg/kg. Conclusion Our study demonstrated that local PDT of arthritic joints is feasible. Application of pegylated liposomal m‐THPC for PDT resulted in significant reduction of arthritis scores. Lasers Surg. Med. 40:265–272, 2008.
- Open Access
- 5 March 2004
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3) , 961-967
In vivo imaging of experimental arthritis with near‐infrared fluorescence
Objective: To visualize early experimental arthritis with near‐infrared fluorescence (NIRF) imaging in a murine model of antigen‐induced arthritis (AIA).Methods: The target of NIRF was the F4/80 antigen present on the surface of macrophages infiltrating the inflamed synovial membrane. Imaging was performed using anti‐F4/80 monoclonal antibodies (mAb) labeled with Cy5.5 fluorochrome. On day 7 of AIA, 6 mice received an intravenous (IV) injection of labeled mAb; control AIA mice (n = 6) received an IV injection of Cy5.5‐labeled isotype control antibody. NIRF imaging was performed before injection (baseline) and until 72 hours thereafter. Histologic evaluation of arthritis severity and immunohistochemical assessment of F4/80 antigen density were also performed on day 7.Results: NIRF imaging showed an accumulation of fluorochrome probes in the inflamed knee joints and, to a lesser extent, in the contralateral (nonarthritic) knee joints. The signal induced by mAb F4/80 was clearly higher than that generated by the isotype control. Accumulation of fluorochrome probes in the joints was confirmed histologically by confocal laser scanning microscopy.Conclusion: The use of fluorochromes allows imaging of arthritis in the near‐infrared range. Accumulation in the contralateral, nonarthritic knee joints can be explained by the presence of sentinel macrophages in normal synovium or by a mild contralateral response due to systemic activation or neurogenic mechanisms.
- 5 March 2004
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3) , 961-967
Open AccessIn vivo imaging of experimental arthritis with near‐infrared fluorescence
Objective: To visualize early experimental arthritis with near‐infrared fluorescence (NIRF) imaging in a murine model of antigen‐induced arthritis (AIA).Methods: The target of NIRF was the F4/80 antigen present on the surface of macrophages infiltrating the inflamed synovial membrane. Imaging was performed using anti‐F4/80 monoclonal antibodies (mAb) labeled with Cy5.5 fluorochrome. On day 7 of AIA, 6 mice received an intravenous (IV) injection of labeled mAb; control AIA mice (n = 6) received an IV injection of Cy5.5‐labeled isotype control antibody. NIRF imaging was performed before injection (baseline) and until 72 hours thereafter. Histologic evaluation of arthritis severity and immunohistochemical assessment of F4/80 antigen density were also performed on day 7.Results: NIRF imaging showed an accumulation of fluorochrome probes in the inflamed knee joints and, to a lesser extent, in the contralateral (nonarthritic) knee joints. The signal induced by mAb F4/80 was clearly higher than that generated by the isotype control. Accumulation of fluorochrome probes in the joints was confirmed histologically by confocal laser scanning microscopy.Conclusion: The use of fluorochromes allows imaging of arthritis in the near‐infrared range. Accumulation in the contralateral, nonarthritic knee joints can be explained by the presence of sentinel macrophages in normal synovium or by a mild contralateral response due to systemic activation or neurogenic mechanisms.